Hubungan Pemberian Magnesium Sulfat (MgS04) pada Persalinan Pre-eklampsia/eklampsia terhadap Kejadian Asfiksia di Rumah Sakit Bhayangkara Makassar Tahun 2014

  • Mardiana Stefania Bhoko STIKes Maranatha Kupang
  • Yosefa Sarlince Atok STIKes Maranatha Kupang
Keywords: MGS04, Asphyxia


MPS's mission is to reduce maternal and neonatal morbidity and mortality through strengthening the health system to ensure access to interventions that are cost effective based
on scientific evidence of quality, empower women, families and communities through activities that promote maternal and newborn health, and ensure that health maternal and neonatal is promoted and preserved as a priority for national development programs. In Indonesia the incidence of preeclampsia and eclampsia ranges from 3 - 10%. According to world data, WHO estimates that more than 160,000 women die each year due to preeclampsia and eclampsia, and this is a cause of death that has been going on for decades. There is still no agreement regarding the exact cause of seizures in patients with eclampsia. Magnesium Sulphate (MgSO4) is one of the selected drugs to prevent seizures in preeclampsia and eclampsia, where the use of magnesium sulfate is effective and safe. The aim of this study was to determine the association of Magnesium Sulphate (MgSO4) in the delivery of Preeclampsia / Eclampsia to Asphyxia in Newborns in 2013 Makassar Bhayangkara. In this study the variables studied were Magnesium Sulphate, Asphyxia. The type of research used in this study is the type of "Case Control" research which is an analytical survey study that deals with how risk factors are studied using a "retrospective" approach. The sample in this study were all patients who fulfilled the inclusion and exclusion criteria who were admitted to Makassar's Bhayangkara Hospital in the January-December 2013 period. For the control group, the sample was taken using proposive sampling. In this study, it can be seen from the chi-square results that there is no correlation between the incidence of asphyxia and the administration of MgSO4 supported by chi-square results, p = 0.65 where p <0.05 Ho is rejected but in this study p> 0.05 or 0.65 > 0.05 means that Ho is accepted.


Mochtar,2003.Sinopsis Obstetri. EGC, Jakarta

Notoatmojo,S.D.2005.Metodologi Penelitian Kesehatan. Penerbit Rineka Cipta. Jakarta.

Noor,H. M. 2007. Panduan Penulisan Skripsi. Program D IV Bidan Pendidik Makassar.

Saifuddin, A. B. 2006. Buku Acuan Nasionsl Pelayanan Kesehatan Maternal Dan Neonatal, YBP – SP, Jakarta. (hal 207- 214).

Saifuddin, A. B. 2010. Buku Acuan Nasionsl Pelayanan Kesehatan Maternal Dan Neonatal, YBP – SP, Jakarta. (hal 207- 214).

Sibai,B. M. Magnesium Sulfat isthe ideal anticonvulsant in Preeklampsia-Eklampsia Am J Obstetri Gynecol 2009.

Sudhaberata, K.Profil Penderita Preeklampsia–Eklampsia di RSU Tarakan, Kaltim,(Online). 022001/art-2.htm, diakses 10 Maret 2014.

Tim Revisi. 2008. Persalinan. EGC, Jakarta

Tomlinson, J. 2008.Labor ward Management of severe Preeklampsia, in : Preeklampsia current perspective on Management. Baker NP,Kingdom CJ, editors. The Parthenon Publishing Group. New York ;2008. p 175- 190.

Wiknjosastro, H. 2006. Ilmu Kebidanan, YBP.SP. Jakarta